Keywords :
APO , myocardial infarction , CAD , coronary artery disease , thrombospondin , apolipoprotein , SNP , Single nucleotide polymorphism , TSP , LTA , MI , LOD , FLAP , 5-lipooxygenase activating protein , logarithm of the odds ratio , lymphotoxin alpha , MEF2A , myocyte-enhancing factor 2A
